BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhangui P, Saigal S, Gautam D, Piplani T, Choudhary N, Chaudhary R, Yadav S, Thiagarajan S, Rastogi A, Saraf N, Nundy S, Soin AS. Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria. Liver Transpl 2021;27:209-21. [PMID: 33253492 DOI: 10.1002/lt.25956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Lerut J, Foguenne M, Lai Q. Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score. Updates Surg 2021. [PMID: 34003479 DOI: 10.1007/s13304-021-01078-4] [Reference Citation Analysis]
2 Sha M, Tong Y, Xia Q. Living Donor Liver Transplantation for Patients With Hepatocellular Carcinoma: What Are the Optimal Criteria? Liver Transpl 2021;27:930-1. [PMID: 33539659 DOI: 10.1002/lt.26003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Biolato M, Galasso T, Marrone G, Miele L, Grieco A. Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation. Cancers (Basel) 2021;13:6337. [PMID: 34944957 DOI: 10.3390/cancers13246337] [Reference Citation Analysis]
4 Bhangui P. Reply. Liver Transpl 2021;27:932-3. [PMID: 33567154 DOI: 10.1002/lt.26008] [Reference Citation Analysis]
5 Ben Khaled N, Roessler D, Reiter FP, Seidensticker M, Guba M, De Toni EN. Extending the Use of Atezolizumab and Bevacizumab to a Liver Transplant Recipient: Need for a Posttransplant Registry. Liver Transpl 2021;27:928-9. [PMID: 33570764 DOI: 10.1002/lt.26011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Choudhary NS, Bhangui P, Soin AS. Liver Transplant Outcomes in India. Clinical Liver Disease 2022;19:32-5. [DOI: 10.1002/cld.1166] [Reference Citation Analysis]